multiple sclerosis

On March 26, the FDA approved Mayzent (siponimod) tablets to treat adults with relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active…

Reader Survey

Please share your feedback! We’re interested to learn more about your experience with American Nurse Journal.

Poll